We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-4.95%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.9B
AUM Growth
-$320M
Cap. Flow
-$202M
Cap. Flow %
-10.62%
Top 10 Hldgs %
7.71%
Holding
2,190
New
419
Increased
603
Reduced
646
Closed
510

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$17.7M
2
SBUX icon
Starbucks
SBUX
+$16.5M
3
WMB icon
Williams Companies
WMB
+$15.6M
4
HRI icon
Herc Holdings
HRI
+$14.9M
5
DAL icon
Delta Air Lines
DAL
+$14M

Top Sells

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$24.9M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$15.2M
3
TJX icon
TJX Companies
TJX
+$14.9M
4
DD
Du Pont De Nemours E I
DD
+$14.4M
5
CTRA
Coterra Energy
CTRA
+$14.2M

Sector Composition

Rank Sector Weight
1 Healthcare 14.76%
2 Consumer Discretionary 13.95%
3 Industrials 12.6%
4 Technology 11%
5 Energy 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MATX icon
351
Matsons
MATX
$6.46B
$1.32M 0.07%
52,600
+38,800
+281% +$1.06M
WFT
352
DELISTED
Weatherford International plc
WFT
$1.31M 0.07%
63,220
-27,034
-30% -$608K
TTWO icon
353
Take-Two Interactive
TTWO
$44.9B
$1.31M 0.07%
+56,638
New +$1.28M
RF icon
354
Regions Financial
RF
$27.3B
$1.3M 0.07%
129,994
-43,262
-25% -$442K
SXCP
355
DELISTED
SunCoke Energy Partners, L.P.
SXCP
$1.3M 0.07%
44,180
+13,480
+44% +$413K
PCRX icon
356
Pacira BioSciences
PCRX
$1.09B
$1.3M 0.07%
+13,371
New +$1.3M
SPXC icon
357
SPX Corp
SPXC
$10.8B
$1.29M 0.07%
54,724
+6,814
+14% +$177K
SYK icon
358
Stryker
SYK
$129B
$1.28M 0.07%
15,890
+9,919
+166% +$816K
MDRX
359
DELISTED
Veradigm Inc. Common Stock
MDRX
$1.28M 0.07%
+95,195
New +$1.44M
CENX icon
360
Century Aluminum
CENX
$4.66B
$1.28M 0.07%
49,138
+7,799
+19% +$172K
BKD icon
361
Brookdale Senior Living
BKD
$3.4B
$1.27M 0.07%
39,577
+11,856
+43% +$404K
JEF icon
362
Jefferies Financial Group
JEF
$12.8B
$1.26M 0.07%
58,899
+8,475
+17% +$191K
ENDP
363
DELISTED
Endo International plc
ENDP
$1.25M 0.07%
18,360
-14,109
-43% -$929K
COO icon
364
Cooper Companies
COO
$14.6B
$1.25M 0.07%
32,028
+2,752
+9% +$108K
PPC icon
365
Pilgrim's Pride
PPC
$6.42B
$1.25M 0.07%
40,784
+17,515
+75% +$529K
ALTO icon
366
Alto Ingredients
ALTO
$410M
$1.24M 0.07%
88,900
+41,600
+88% +$782K
CRD.B icon
367
Crawford & Co Class B
CRD.B
$555M
$1.24M 0.07%
150,247
+19,260
+15% +$181K
GME icon
368
GameStop
GME
$8.62B
$1.24M 0.07%
119,880
+70,464
+143% +$749K
MUR icon
369
Murphy Oil
MUR
$5.5B
$1.24M 0.07%
21,694
-17,409
-45% -$1.08M
LMNX
370
DELISTED
Luminex Corp
LMNX
$1.23M 0.06%
63,184
-14,000
-18% -$256K
JAZZ icon
371
Jazz Pharmaceuticals
JAZZ
$16.4B
$1.23M 0.06%
7,657
-5,167
-40% -$794K
PAG icon
372
Penske Automotive Group
PAG
$14.4B
$1.22M 0.06%
30,138
+10,458
+53% +$491K
CLCT
373
DELISTED
Collectors Universe
CLCT
$1.22M 0.06%
55,540
+17,775
+47% +$359K
NPSP
374
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$1.22M 0.06%
47,018
+13,681
+41% +$393K
RGC
375
DELISTED
Regal Entertainment Group
RGC
$1.22M 0.06%
61,282
+41,522
+210% +$851K
13 14
15
16 17

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q3 2014 Portfolio in Review

As of Q3 2014, GSA Capital Partners held 2,190 positions worth $1.9B, down 14% from $2.22B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

GSA Capital Partners withdrew a net $202M in Q3 2014, closing 510 positions and reducing 646 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, GSA Capital Partners opened a new position in Illumina worth $16.9M.

  • GSA Capital Partners's largest Q3 2014 buy was Illumina: 105,983 shares worth $16.9M.
  • GSA Capital Partners added most to Williams Companies in Q3 2014, an estimated $15.6M increase.
  • GSA Capital Partners's biggest Q3 2014 reduction was Marathon Petroleum, cutting an estimated $24.9M.
  • GSA Capital Partners fully exited Regeneron Pharmaceuticals in Q3 2014, selling an estimated $15.2M.
  • GSA Capital Partners's ten largest holdings make up 7.7% of its $1.9B portfolio in Q3 2014.
  • GSA Capital Partners opened 419 new positions and closed 510 in Q3 2014.
  • GSA Capital Partners's portfolio value fell 14% quarter-over-quarter to $1.9B.

Based on GSA Capital Partners's 13F filing for Q3 2014, filed 6 Nov 2014.